Black Rock Inc. Akero Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,892,616 shares of AKRO stock, worth $115 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,892,616

Previous 4,180,507 17.03%

Holding current value

$115 Million

Previous $97.6 Million 26.61%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $12.6 Million - $22.2 Million	712,109 Added 17.03%	4,892,616 $124 Million
Q4 2023 Feb 13, 2024	BUY	$11.38 - $50.33 $2.31 Million - $10.2 Million	203,187 Added 5.11%	4,180,507 $97.6 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $27 Million - $34.3 Million	656,167 Added 19.76%	3,977,320 $201 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $19.8 Million - $30.6 Million	537,776 Added 19.32%	3,321,153 $155 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $50.24 $926,084 - $1.25 Million	24,848 Added 0.9%	2,783,377 $106 Million

Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $13.8 Million - $22.6 Million	413,052 Added 17.61%	2,758,529 $151 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $2.58 Million - $8.66 Million	254,236 Added 12.16%	2,345,477 $79.9 Million
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $1.57 Million - $2.94 Million	195,713 Added 10.32%	2,091,241 $19.8 Million
Q1 2022 May 12, 2022	SELL	$12.97 - $22.26 $630,264 - $1.08 Million	-48,594 Reduced 2.5%	1,895,528 $26.9 Million
Q4 2021 Feb 10, 2022	BUY	$19.87 - $26.24 $1.54 Million - $2.04 Million	77,565 Added 4.16%	1,944,122 $41.1 Million
Q3 2021 Nov 09, 2021	BUY	$18.65 - $25.46 $348,922 - $476,331	18,709 Added 1.01%	1,866,557 $41.7 Million
Q2 2021 Aug 11, 2021	BUY	$24.81 - $32.35 $45.8 Million - $59.8 Million	1,847,848 New	1,847,848 $45.8 Million

Others Institutions Holding AKRO

# of Institutions

193

Shares Held

74.2M

Call Options Held

429K

Put Options Held

591K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.09B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account